Blood Products Advisory Committee
This article was originally published in The Gray Sheet
Executive Summary
Meeting March 25-26 in Bethesda, Maryland. On March 25, the committee is scheduled to review a product license application for a peptide based assay for antibody to hepatitis C virus and discuss donor screening for HTLV-II. On March 26, the committee will review two draft memoranda: "Revised Recommendations for Testing for Antibody to Anti-HCV" and "Licensing Requirements for Irradiated Blood Products." The committee also is scheduled to discuss extending the indications for intravenous immune globulin. Contact person is Linda Smallwood at (301) 227- 6700.